Kraig Biocraft Laboratories, Inc.
KBLB· OTC
KBLBKraig Biocraft Laboratories, Inc.
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001493152-25-021953
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$1.51M | -$433.20K | -$549.27K | -$810.36K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end
